Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2087144560', 'doi': 'https://doi.org/10.1089/aid.2008.0222', 'title': 'Raltegravir and Etravirine Are Active against HIV Type 1 Group O', 'display_name': 'Raltegravir and Etravirine Are Active against HIV Type 1 Group O', 'publication_year': 2009, 'publication_date': '2009-02-01', 'ids': {'openalex': 'https://openalex.org/W2087144560', 'doi': 'https://doi.org/10.1089/aid.2008.0222', 'mag': '2087144560', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/19239363'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1089/aid.2008.0222', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S161282271', 'display_name': 'AIDS Research and Human Retroviruses', 'issn_l': '0889-2229', 'issn': ['0889-2229', '1931-8405'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320443', 'host_organization_name': 'Mary Ann Liebert, Inc.', 'host_organization_lineage': ['https://openalex.org/P4310320443'], 'host_organization_lineage_names': ['Mary Ann Liebert, Inc.'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5030366995', 'display_name': 'Verónica Briz', 'orcid': 'https://orcid.org/0000-0003-2297-5098'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Verónica Briz', 'raw_affiliation_strings': ['Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011164078', 'display_name': 'Carmen Garrido', 'orcid': 'https://orcid.org/0000-0003-1368-1493'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Carolina Garrido', 'raw_affiliation_strings': ['Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057854777', 'display_name': 'Eva Poveda', 'orcid': 'https://orcid.org/0000-0003-4835-9875'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Eva Poveda', 'raw_affiliation_strings': ['Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5016018012', 'display_name': 'Judit Morelló', 'orcid': 'https://orcid.org/0000-0002-1148-9329'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Judit Morello', 'raw_affiliation_strings': ['Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5003553956', 'display_name': 'Pablo Barreiro', 'orcid': 'https://orcid.org/0000-0002-3819-5371'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Pablo Barreiro', 'raw_affiliation_strings': ['Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019171058', 'display_name': 'Carmen de Mendoza', 'orcid': 'https://orcid.org/0000-0001-5224-7492'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Carmen de Mendoza', 'raw_affiliation_strings': ['Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5009751300', 'display_name': 'Vincent Soriano', 'orcid': 'https://orcid.org/0000-0002-4624-5199'}, 'institutions': [], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Vincent Soriano', 'raw_affiliation_strings': ['Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.'], 'affiliations': [{'raw_affiliation_string': 'Department of Infectious Disease, Hospital Carlos III, Madrid, Spain 28040.', 'institution_ids': []}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 4.26, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 44, 'citation_normalized_percentile': {'value': 0.824132, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': '25', 'issue': '2', 'first_page': '225', 'last_page': '227'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'Efficacy and Safety of Antiretroviral Therapy for HIV', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'Efficacy and Safety of Antiretroviral Therapy for HIV', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10112', 'display_name': 'Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10151', 'display_name': 'Hepatitis C Infection and Treatment', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2721', 'display_name': 'Hepatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/etravirine', 'display_name': 'Etravirine', 'score': 0.99482894}, {'id': 'https://openalex.org/keywords/raltegravir', 'display_name': 'Raltegravir', 'score': 0.9868777}, {'id': 'https://openalex.org/keywords/enfuvirtide', 'display_name': 'Enfuvirtide', 'score': 0.70988053}, {'id': 'https://openalex.org/keywords/maraviroc', 'display_name': 'Maraviroc', 'score': 0.69931936}, {'id': 'https://openalex.org/keywords/antiretroviral-therapy', 'display_name': 'Antiretroviral Therapy', 'score': 0.545047}, {'id': 'https://openalex.org/keywords/hiv', 'display_name': 'HIV', 'score': 0.502903}], 'concepts': [{'id': 'https://openalex.org/C2780345285', 'wikidata': 'https://www.wikidata.org/wiki/Q414762', 'display_name': 'Etravirine', 'level': 5, 'score': 0.99482894}, {'id': 'https://openalex.org/C2780404665', 'wikidata': 'https://www.wikidata.org/wiki/Q421552', 'display_name': 'Raltegravir', 'level': 5, 'score': 0.9868777}, {'id': 'https://openalex.org/C2778037500', 'wikidata': 'https://www.wikidata.org/wiki/Q423327', 'display_name': 'Enfuvirtide', 'level': 5, 'score': 0.70988053}, {'id': 'https://openalex.org/C2778899366', 'wikidata': 'https://www.wikidata.org/wiki/Q421369', 'display_name': 'Maraviroc', 'level': 3, 'score': 0.69931936}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.5293703}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.46034387}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.39605153}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.3935771}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.35177588}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.2547984}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.17401993}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.11337158}, {'id': 'https://openalex.org/C2776258796', 'wikidata': 'https://www.wikidata.org/wiki/Q5590520', 'display_name': 'Gp41', 'level': 4, 'score': 0.05670455}, {'id': 'https://openalex.org/C147483822', 'wikidata': 'https://www.wikidata.org/wiki/Q103537', 'display_name': 'Antigen', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C195616568', 'wikidata': 'https://www.wikidata.org/wiki/Q128711', 'display_name': 'Epitope', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000821', 'qualifier_name': 'virology', 'is_major_topic': True}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D011724', 'descriptor_name': 'Pyridazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D011760', 'descriptor_name': 'Pyrrolidinones', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D019943', 'descriptor_name': 'Amino Acid Substitution', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D019943', 'descriptor_name': 'Amino Acid Substitution', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D024882', 'descriptor_name': 'Drug Resistance, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020125', 'descriptor_name': 'Mutation, Missense', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011724', 'descriptor_name': 'Pyridazines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011724', 'descriptor_name': 'Pyridazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011760', 'descriptor_name': 'Pyrrolidinones', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D011760', 'descriptor_name': 'Pyrrolidinones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012367', 'descriptor_name': 'RNA, Viral', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D012367', 'descriptor_name': 'RNA, Viral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068898', 'descriptor_name': 'Raltegravir Potassium', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019562', 'descriptor_name': 'Viral Load', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1089/aid.2008.0222', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S161282271', 'display_name': 'AIDS Research and Human Retroviruses', 'issn_l': '0889-2229', 'issn': ['0889-2229', '1931-8405'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320443', 'host_organization_name': 'Mary Ann Liebert, Inc.', 'host_organization_lineage': ['https://openalex.org/P4310320443'], 'host_organization_lineage_names': ['Mary Ann Liebert, Inc.'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/19239363', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.86, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 7, 'referenced_works': ['https://openalex.org/W2053125329', 'https://openalex.org/W2059707387', 'https://openalex.org/W2128945494', 'https://openalex.org/W2133758885', 'https://openalex.org/W2150504993', 'https://openalex.org/W2172130850', 'https://openalex.org/W86894734'], 'related_works': ['https://openalex.org/W4293228629', 'https://openalex.org/W2415094934', 'https://openalex.org/W2345792706', 'https://openalex.org/W2316050656', 'https://openalex.org/W2153983401', 'https://openalex.org/W2087144560', 'https://openalex.org/W2082257783', 'https://openalex.org/W2036395208', 'https://openalex.org/W2033359910', 'https://openalex.org/W2020388319'], 'abstract_inverted_index': {'The': [0], 'activity': [1], 'of': [2, 18], 'raltegravir': [3, 26, 71], 'and': [4, 31, 33], 'etravirine': [5, 34, 73], 'was': [6, 46, 57], 'assessed': [7], 'in': [8, 10, 48, 54], 'vitro': [9], 'HIV-1': [11, 50, 65], 'group': [12, 51, 66], 'O': [13, 67], 'isolates.': [14], 'Despite': [15], 'the': [16, 43], 'presence': [17], 'some': [19], 'natural': [20], 'polymorphisms': [21], 'associated': [22], 'with': [23, 64], 'resistance': [24], 'to': [25], '(V72I,': [27], 'L74I,': [28], 'S153A,': [29], 'V201I,': [30], 'T206S)': [32], '(G190A),': [35], 'both': [36], 'drugs': [37], 'showed': [38], 'significant': [39], 'antiviral': [40], 'activity.': [41], 'Subsequently,': [42], 'clinical': [44], 'benefit': [45, 69], 'shown': [47], 'an': [49], 'O-infected': [52], 'individual': [53], 'whom': [55], 'enfuvirtide': [56], 'replaced': [58], 'by': [59], 'raltegravir.': [60], 'Therefore,': [61], 'individuals': [62], 'infected': [63], 'might': [68], 'from': [70], 'and/or': [72], 'therapy.': [74]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2087144560', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 4}, {'year': 2013, 'cited_by_count': 5}, {'year': 2012, 'cited_by_count': 8}], 'updated_date': '2024-08-13T15:20:45.731046', 'created_date': '2016-06-24'}